UBS Group’s Scinai Immunotherapeutics SCNI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.5K Sell
12,056
-2,876
-19% -$6.56K ﹤0.01% 6919
2025
Q1
$40.2K Sell
14,932
-8,556
-36% -$23.1K ﹤0.01% 6451
2024
Q4
$78.6K Buy
23,488
+23,458
+78,193% +$78.5K ﹤0.01% 5807
2024
Q3
$104 Sell
30
-181
-86% -$627 ﹤0.01% 7938
2024
Q2
$586 Sell
211
-1
-0.5% -$3 ﹤0.01% 7689
2024
Q1
$1.1K Hold
212
﹤0.01% 7058
2023
Q4
$1.26K Buy
212
+130
+159% +$773 ﹤0.01% 7144
2023
Q3
$717 Buy
82
+51
+165% +$446 ﹤0.01% 7167
2023
Q2
$431 Sell
31
-501
-94% -$6.97K ﹤0.01% 7153
2023
Q1
$11.5K Buy
532
+502
+1,673% +$10.8K ﹤0.01% 6407
2022
Q4
$888 Sell
30
-50
-63% -$1.48K ﹤0.01% 8844
2022
Q3
$6K Buy
80
+33
+70% +$2.48K ﹤0.01% 7952
2022
Q2
$5K Sell
47
-56
-54% -$5.96K ﹤0.01% 7885
2022
Q1
$17K Buy
103
+31
+43% +$5.12K ﹤0.01% 6622
2021
Q4
$16K Buy
72
+45
+167% +$10K ﹤0.01% 7059
2021
Q3
$6K Buy
27
+11
+69% +$2.44K ﹤0.01% 7291
2021
Q2
$5K Buy
+16
New +$5K ﹤0.01% 7457
2021
Q1
Hold
0
8184
2020
Q3
Sell
-19
Closed -$43K 7350
2020
Q2
$43K Buy
+19
New +$43K ﹤0.01% 5148
2019
Q2
Sell
-9
Closed -$5K 7116
2019
Q1
$5K Sell
9
-21
-70% -$11.7K ﹤0.01% 6341
2018
Q4
$14K Sell
30
-16
-35% -$7.47K ﹤0.01% 6125
2018
Q3
$25K Buy
46
+33
+254% +$17.9K ﹤0.01% 5760
2018
Q2
$8K Sell
13
-8
-38% -$4.92K ﹤0.01% 6345
2018
Q1
$11K Buy
+21
New +$11K ﹤0.01% 5928
2016
Q4
Sell
-1
Closed 6879
2016
Q3
$0 Sell
1
-13
-93% ﹤0.01% 6817
2016
Q2
$5K Buy
+14
New +$5K ﹤0.01% 6228
2015
Q4
Sell
-35
Closed -$13K 6989
2015
Q3
$13K Buy
35
+9
+35% +$3.34K ﹤0.01% 5766
2015
Q2
$13K Buy
+26
New +$13K ﹤0.01% 5820